Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-12-19
1982-03-23
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 7, 424 9, 424 49, A61K 600, G01N 130, G01N 3348
Patent
active
043212514
ABSTRACT:
A method of clinical diagnosis and a composition for detecting malignant lesions of the oral cavity by utilizing as a rinse, toluidine blue preferably in acetic solution of water and ethanol. A preferred rinse is 5 cc 1% toluidine blue solution which is utilized in 1% acetic acid and water. In the method the solution (5-10 cc) is poured into floor of mouth and patient is advised to rinse and gargle.
REFERENCES:
Strong, Arch. Otolaryng, vol. 87, May 1968, pp. 101-105.
Niebel, J. Amer. Dent. Assoc., vol. 68, 1964, pp. 801-806.
Shedd, Amer. J. Surg., vol. 110, 1965, pp. 631-634.
Shedd, Arch. Surg., vol. 95, 1967, pp. 16-22.
Vaughan, Otolaryng, Clin. of NA, vol. 5, 1972, pp. 301-302.
Ross, "Notes & Comments," Dental Abs., vol. 13, 1968, p. 453.
Mashberg, Cancer, Pub. pending.
Benveniste, Chem. Abs., vol. 86, 1977, Ab. No. 86:102805j.
Fagelson Anna P.
Roberts, Jr. John S.
The United States of America as represented by the Department of
LandOfFree
Detection of malignant lesions of the oral cavity utilizing tolu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of malignant lesions of the oral cavity utilizing tolu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of malignant lesions of the oral cavity utilizing tolu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1650725